PATENT CLAIM ANALYSIS

Application Number: 16037655
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "496000"]

Abstract:
Disclosed herein are forms of L-ornithine phenyl acetate and methods of making the same. A crystalline form may, in some embodiments, be Forms I, II, III and V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate.

Claim (Index 15):
The process of  claim 5 , wherein said crystallizing provides a composition comprising a crystalline form of L-ornithine phenylacetate, wherein said crystalline form exhibits an X-ray powder diffraction pattern comprising at least three characteristic peaks, wherein said characteristic peaks are selected from the group consisting of peaks at approximately 4.9\u00b0, 13.2\u00b0, 17.4\u00b0, 20.8\u00b0 and 24.4\u00b0 2\u03b8.

Metadata:
- Claim Count in Document: 42.0
- Percentile: 95.0
- Lexical Diversity: 1.48936
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15469359', '13436642', '12753763', '13937107', '14299940']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.773974134387573
- 35 USC 102 Novelty (BERT): 0.5887500048622483
- Combined Prediction Score: 0.7554517214350406
- Mean Citation Score: 451.049608
- Max Citation Score: 496.4344
- Similarity Product: 435.0884797178268

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test